NCT03217409View on ClinicalTrials.gov

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

April 3, 2019

Study Completion Date

May 23, 2019

Conditions
Diabetes Mellitus and Hypercholesterolemia
Interventions
DRUG

Rosuvastatin+Ezetimibe

Rosuvastatin 5mg+Ezetimibe 10mg

DRUG

Rosuvastatin

Rosuvastatin 5Mg Tablet

Trial Locations (4)

Unknown

Soon Chun Hyang University Hospital Cheonan, Cheonan

Soon Chun Hyang University Hospital Gumi, Gumi

Soon Chun Hyang University Hospital Bucheon, Gyeonggi-do

Soon Chun Hyang University Hospital Seoul, Seoul

Sponsors

Collaborators (1)

Linical Korea
All Listed Sponsors
collaborator

Linical Korea

INDUSTRY

lead

Yuhan Corporation

INDUSTRY

NCT03217409 - A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia | Biotech Hunter | Biotech Hunter